Cibc World Markets Corp Sells 11,438 Shares of CME Group Inc. (NASDAQ:CME)

Cibc World Markets Corp cut its holdings in CME Group Inc. (NASDAQ:CME) by 11.1% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 91,472 shares of the financial services provider’s stock after selling 11,438 shares during the period. Cibc World Markets Corp’s holdings in CME Group were worth $19,454,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also added to or reduced their stakes in the company. Certified Advisory Corp purchased a new position in CME Group in the first quarter valued at approximately $27,000. Solstein Capital LLC purchased a new position in CME Group in the first quarter valued at approximately $28,000. Capital Analysts LLC lifted its stake in CME Group by 370.0% in the first quarter. Capital Analysts LLC now owns 188 shares of the financial services provider’s stock valued at $38,000 after purchasing an additional 148 shares during the last quarter. RE Advisers Corp purchased a new position in CME Group in the second quarter valued at approximately $38,000. Finally, Simon Quick Advisors LLC lifted its stake in CME Group by 33.3% in the first quarter. Simon Quick Advisors LLC now owns 200 shares of the financial services provider’s stock valued at $40,000 after purchasing an additional 50 shares during the last quarter. 86.19% of the stock is owned by institutional investors.

CME opened at $188.85 on Wednesday. The stock has a market cap of $67.82 billion, a PE ratio of 35.30 and a beta of 0.43. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 52 week low of $146.89 and a 52 week high of $221.82. The business’s fifty day simple moving average is $204.38 and its 200 day simple moving average is $208.14.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, July 28th. The financial services provider reported $1.64 EPS for the quarter, beating the Zacks’ consensus estimate of $1.59 by $0.05. The business had revenue of $1.18 billion for the quarter, compared to analysts’ expectations of $1.17 billion. CME Group had a return on equity of 8.33% and a net margin of 41.64%. As a group, equities analysts anticipate that CME Group Inc. will post 6.65 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Monday, September 27th. Investors of record on Friday, September 10th will be paid a $0.90 dividend. The ex-dividend date of this dividend is Thursday, September 9th. This represents a $3.60 dividend on an annualized basis and a yield of 1.91%. CME Group’s dividend payout ratio is presently 53.57%.

In other news, Director Martin J. Gepsman sold 1,000 shares of the firm’s stock in a transaction dated Monday, August 23rd. The stock was sold at an average price of $201.37, for a total transaction of $201,370.00. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Sean Tully sold 5,000 shares of the stock in a transaction dated Tuesday, August 24th. The stock was sold at an average price of $200.20, for a total transaction of $1,001,000.00. Following the sale, the insider now owns 23,479 shares of the company’s stock, valued at $4,700,495.80. The disclosure for this sale can be found here. In the last three months, insiders sold 9,000 shares of company stock worth $1,786,150. 0.30% of the stock is owned by insiders.

Several equities research analysts have issued reports on CME shares. Atlantic Securities upgraded CME Group from a “neutral” rating to an “overweight” rating and set a $230.00 target price on the stock in a research report on Tuesday. TheStreet downgraded CME Group from a “b” rating to a “c+” rating in a research report on Wednesday, August 18th. Morgan Stanley increased their target price on CME Group from $228.00 to $229.00 and gave the stock an “equal weight” rating in a research report on Thursday, July 1st. Finally, Berenberg Bank restated a “hold” rating on shares of CME Group in a research report on Wednesday. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $210.83.

About CME Group

CME Group, Inc operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals.

See Also: How is a management fee different from a performance fee?

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.